Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 283-284 , February 2007

Optimizing adult mesenchymal stem cells for heart repair

Received 6 November 2006

References 

  1. Bell J. Predicting disease using genomics. Nature. 2004;429:453–456
  2. Watkins H, Farrall M. Genetic susceptibility to coronary artery disease: from promise to progress. Nat. Rev., Genet. 2006;7:163–173
  3. Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature. 2002;415:240–243
  4. Dimmeler S, Zeiher A, Schneider M. Unchain my heart: scientific foundations of cardiac repair. J. Clin. Invest. 2005;115:572–583
  5. Murry CE, Field LJ, Menasché P. Cell-based cardiac repair: reflections at the 10-year point. Circulation. 2005;112:3174–3183
  6. Sanchez P, San Roman J, Villa A, Fernandez M, Fernandez-Aviles F. Contemplating the bright future of stem cell therapy for cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 2006;3:S138–S151
  7. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 2006;355:1210–1221
  8. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N. Engl. J. Med. 2006;355:1274–1277
  9. Laflamme MA, Murry CE. Regenerating the heart. Nat. Biotechnol. 2005;23:845–856
  10. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 2005;11:367–368
  11. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 2006;12:459–465
  12. Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren J, et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J. Exp. Med. 2006;203:2315–2327
  13. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 2006;98:1414–1421
  14. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41–49
  15. Li XH, Yu XY, Lin QX, Deng CY, Shan ZX, Yang M, et al. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J. Mol. Cell. Cardiol. 2007;
  16. Behfar A, Zingman L, Hodgson D, Rauzier J, Kane G, Terzic A, et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 2002;16:1558–1566
  17. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 1999;100:II247–II256
  18. Deb A, Wang S, Skelding KA, Miller D, Simper D, Caplice NM. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation. 2003;107:1247–1249
  19. Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink R, et al. Differentiation of human embryonic stem cells to cardiomyocytes. Circulation. 2003;107:2733–2740
  20. Behfar A, Terzic A. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nat. Clin. Pract. Cardiovasc. Med. 2006;3:S78–S82
  21. Chien KR. Lost and found: cardiac stem cell therapy revisited. J. Clin. Invest. 2006;116:1838–1840

PII: S0022-2828(06)01023-6

doi: 10.1016/j.yjmcc.2006.11.003

Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 283-284 , February 2007

Article Tools